Haemonetics Corp. (HAE) Tops Q3 EPS by 3c; Reaffirms Outlook

Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $247.4 million versus the consensus estimate of $251.93 million.

Reaffirmed FY13 and FY14 guidance.

For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Cisco rating cut at HSBC as analyst sees a lack of catalysts
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat